台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    71.1
  • 漲跌
    ▼1.7
  • 漲幅
    -2.34%
  • 成交量
    205
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
旭富 (4119)籌碼相關-凱基-東勢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-東勢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/11069.6000.0071.1001680.02%
2025/04/010.178.8000.0078.000.11420.07%
2025/03/190.183.2000.0083.100.11450.03%
2025/03/120.183.9000.0083.400.11570.03%
2025/03/050.186.4000.0085.800.11760.03%
2025/03/040.186.1000.0086.100.11780.04%
2025/02/12086.9000.0086.4002800.01%
2025/02/07086.0000.0086.0002780.01%
2025/02/0600.000.185.5085.90-0.1277-0.05%
2025/02/05084.4900.0084.4002750.01%
2025/01/14083.8000.0084.0002700.01%
2025/01/130.184.1100.0083.900.12690.04%
2024/12/30091.9000.0090.9002480.02%
2024/12/27091.3000.0091.3002500.01%
2024/12/0400.00097.8097.800216-0.01%
2024/11/2800.00095.0095.000197-0.01%
2024/11/1900.000.195.8096.10-0.1155-0.04%
2024/11/1800.000.195.4696.00-0.1151-0.09%
2024/11/1500.000.195.3195.50-0.1147-0.06%
2024/11/110.193.8000.0093.300.11120.09%
2024/11/08089.9700.0090.400950.03%
2024/11/05089.4000.0089.600990.04%
2024/10/24089.3000.0089.6001180.02%
2024/10/140.190.1200.0090.500.11330.04%
2024/09/19088.0000.0088.3001480.02%
2024/08/0700.001.190.6990.50-1.1210-0.54%
2024/08/0100.000.192.0092.20-0.1204-0.05%
2024/07/190.191.3600.0091.600.12010.03%
2024/07/180.292.3300.0092.700.21990.08%
2024/07/170.192.39192.4092.60-0.9196-0.44%
2024/07/080.390.9800.0091.300.32030.12%
2024/07/050.191.20191.5091.30-0.9203-0.44%
2024/07/0400.00091.4091.2002050.00%
2024/07/010.389.7900.0089.900.32030.13%
2024/06/280.390.1000.0090.400.32050.14%
2024/06/2700.000.190.3090.10-0.1204-0.07%
2024/06/2600.000.290.5090.50-0.2203-0.09%
2024/06/1700.000.390.8090.80-0.3208-0.15%
2024/06/120.790.5000.0090.400.72110.35%
2024/06/110.191.7500.0090.200.12140.06%
2024/05/310.192.6000.0092.000.12300.02%
2024/05/3000.00192.6092.50-1230-0.43%
2024/05/290.792.2000.0092.300.72340.31%
2024/05/272393.33293.1093.10212348.95%
2024/05/230.191.6500.0091.300.12350.03%
2024/05/210.192.4100.0092.100.12350.06%
2024/05/200.293.2400.0093.400.22330.06%
2024/05/170.393.9000.0093.900.32300.13%
2024/05/16091.4000.0092.5002250.02%
2024/05/14091.2000.0091.2002290.02%
2024/05/0200.002588.4288.80-25244-10.22%
2024/04/30088.9000.0089.0002450.02%
2024/04/290.188.9700.0089.200.12460.06%
2024/04/240.187.8000.0087.800.12450.02%
2024/04/22186.3000.0086.5012540.39%
2024/04/182588.5900.0088.302525010.00%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章